Start Over

Deep cutaneous fungal infections in solid-organ transplant recipients.

Authors :: Galezowski A
Delyon J
Le Cleach L
Guégan S
Ducroux E
Alanio A
Lastennet D
Moguelet P
Dadban A
Leccia MT
Le Pelletier F
Francès C
Lebbé C
Barete S
Source :: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2020 Aug; Vol. 83 (2), pp. 455-462. Date of Electronic Publication: 2020 Jan 11.
Publication Year :: 2020
Abstract: Background: Deep cutaneous fungal infections (DCFIs) are varied in immunosuppressed patients, with few data for such infections in solid-organ transplant recipients (s-OTRs). Objective: To determine DCFI diagnostic characteristics and outcome with treatments in s-OTRs. Methods: A 20-year retrospective observational study in France was conducted in 8 primary dermatology-dedicated centers for s-OTRs diagnosed with DCFIs. Relevant clinical data on transplants, fungal species, treatments, and outcomes were analyzed. Results: Overall, 46 s-OTRs developed DCFIs (median delay, 13 months after transplant) with predominant phaeohyphomycoses (46%). Distribution of nodular lesions on limbs and granulomatous findings on histopathology were helpful diagnostic clues. Treatments received were systemic antifungal therapies (48%), systemic antifungal therapies combined with surgery (28%), surgery alone (15%), and modulation of immunosuppression (61%), leading to complete response in 63% of s-OTRs. Limitations: Due to the retrospective observational design of the study. Conclusions: Phaeohyphomycoses are the most common DCFIs in s-OTRs. Multidisciplinary teams are helpful for optimal diagnosis and management. (Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)